Tenaya Therapeutics Inc (TNYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -28,077 | -17,782 | -9,051 | 0 |
| Depreciation Amortization | 1,825 | 1,194 | 584 | 0 |
| Accounts payable and accrued liabilities | 527 | 422 | 674 | N/A |
| Other Working Capital | 709 | 626 | 21 | 0 |
| Other Operating Activity | -30 | 28 | -466 | 0 |
| Operating Cash Flow | $-25,046 | $-15,512 | $-8,238 | $0 |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | 2,753 | 2,753 | 2,753 | N/A |
| PPE Investments | -1,586 | -1,424 | -435 | 0 |
| Investing Cash Flow | $1,167 | $1,329 | $2,318 | $0 |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 17 | 5 | 3 | N/A |
| Common Stock Repurchased | -1 | N/A | N/A | N/A |
| Other Financing Activity | 61,328 | 30,644 | 30,667 | 0 |
| Financing Cash Flow | $61,344 | $30,649 | $30,670 | $0 |
| Beginning Cash Position | 24,271 | 24,271 | 24,271 | 0 |
| End Cash Position | 61,736 | 40,737 | 49,021 | 0 |
| Net Cash Flow | $37,465 | $16,466 | $24,750 | $0 |
| Free Cash Flow | ||||
| Operating Cash Flow | -25,046 | -15,512 | -8,238 | 0 |
| Capital Expenditure | -1,586 | -1,424 | -435 | N/A |
| Free Cash Flow | -26,632 | -16,936 | -8,673 | 0 |